Got an FDA warning letter? Read it properly in ten minutes.

A plain-English guide for recipients. Verify everything yourself, at the source, before you trust anyone — including me.

If you've learned — from a certified letter, an email from FDA, or an email like mine — that the agency has issued a warning letter about your products, the most grounding thing you can do is read the letter the way the agency wrote it. It has a fixed anatomy, and each part tells you something specific about what happens next.

Step 1 — Find the official copy

FDA publishes warning letters at fda.gov's warning-letter database — public, searchable, no account needed. Letters usually post a few days after they're issued. Search your company name; the entry shows the issuing office, the issue date, and the posting date. If someone emailed you about your letter (I do this), check that what they sent matches what the agency published. The reference number — it looks like MARCS-CMS 735346 — is the letter's ID; quote it in all correspondence.

Step 2 — Find the legal core

Somewhere in the first paragraphs the letter states the violation class. For website-claims letters about supplements, topicals, and similar products, the core is almost always this: your marketing makes the product a drug — because it claims to treat, cure, mitigate, or prevent a disease — and the product isn't an approved drug. The letter may add misbranding counts. The important practical consequence: the problem lives in your words and images, not your formula. That's why the remediation is website work.

Step 3 — Read the quotes. They're the to-do list.

The middle of the letter quotes your own pages: product names, headlines, bullet copy, testimonial lines, sometimes image captions and marketplace listings — each with the URL it was captured from, and a capture date. This section is the entire scope of the website problem. Nothing needs guessing: the agency has told you, verbatim, which language it objects to and where it saw it. Anything that repeats the same pattern elsewhere on your site belongs on the list too, even if the letter didn't quote it — the letter typically says exactly that ("the claims listed are not intended to be an all-inclusive list").

Step 4 — The response paragraph

Near the end, the letter asks you to respond in writing within fifteen working days of receipt, describing the specific steps you've taken to address the violations — with documentation — or your timeline and reasons if corrections will take longer. Two things worth understanding precisely: the clock runs from when you received the letter, and the deadline is for a response, not necessarily finished corrections. A response that shows documented corrections in motion is a real response. Who writes it is a legal decision — that's counsel's document, built on the record of what actually changed on your site.

Step 5 — Know what closes it

FDA runs a close-out process: after it verifies corrections, it can issue a close-out letter, which is also posted publicly. That's the finish line. Between your response and close-out, the practical work is making the corrections real, complete, and documented — every quoted claim rewritten or removed, the same patterns swept site-wide, and a record of what changed and when.

Where I fit, if anywhere

I'm an independent web compliance engineer — the inventory, the rewrite, the sweep, and the correction log are my work; the response letter and all strategy are your counsel's. If I wrote to you, the claims inventory came free and it's yours to hand to anyone. Nothing in the letter, this page, or my email is legal advice.

Contact

Email [email protected]. You'll get a reply from me — usually the same day, always from a person.